在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Rat Alpha-synuclein(SNCA) ELISA kit

  • 中文名稱:
    大鼠α-突觸核蛋白(SNCA)酶聯免疫試劑盒
  • 貨號:
    CSB-EL021912RA
  • 規格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人α-突觸核蛋白(SNCA)酶聯免疫試劑盒(CSB-EL021912RA)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的SNCA含量。SNCA靶點編碼α - 突觸核蛋白,其基因突變或異常聚集與帕金森病等神經退行性疾病密切相關。研究機制主要圍繞其在神經元中的正常功能、錯誤折疊與聚集過程,以及對神經細胞的毒性作用,旨在為相關疾病的防治提供方向。試劑盒檢測范圍為0.625 ng/mL-40 ng/mL,可廣泛應用于神經退行性疾病模型構建、藥物干預效果評估或蛋白表達調控機制研究等領域,為探索SNCA相關病理生理過程提供可靠工具。本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    Snca ELISA Kit; Alpha-synuclein ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Rattus norvegicus (Rat)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.625 ng/mL-40 ng/mL
  • 靈敏度:
    0.156 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Neuroscience
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%      
    Three samples of known concentration were tested twenty times on one plate to assess.  
    Inter-assay Precision (Precision between assays): CV%<10%      
    Three samples of known concentration were tested in twenty assays to assess.    
                 
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of rat SNCA in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
      Sample Serum(n=4)  
    1:1 Average % 86  
    Range % 82-90  
    1:2 Average % 102  
    Range % 97-105  
    1:4 Average % 98  
    Range % 94-101  
    1:8 Average % 98  
    Range % 91-102  
  • 回收率:
    The recovery of rat SNCA spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range  
    Serum (n=5) 92 88-95  
    EDTA plasma (n=4) 94 87-97  
                 
                 
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1 OD2 Average Corrected  
    40 2.532 2.500 2.516 2.403  
    20 2.099 2.012 2.056 1.943  
    10 1.401 1.432 1.417 1.304  
    5 0.906 0.921 0.914 0.801  
    2.5 0.566 0.577 0.572 0.459  
    1.25 0.345 0.358 0.352 0.239  
    0.625 0.242 0.237 0.240 0.127  
    0 0.112 0.114 0.113    
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 功能:
    Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release. Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores. Mechanistically, acts by increasing local Ca(2+) release from microdomains which is essential for the enhancement of ATP-induced exocytosis. Acts also as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5. This chaperone activity is important to sustain normal SNARE-complex assembly during aging. Plays also a role in the regulation of the dopamine neurotransmission by associating with the dopamine transporter (DAT1) and thereby modulating its activity.
  • 基因功能參考文獻:
    1. Calcium binds to the C terminus of alpha-synuclein, therewith increasing its lipid-binding capacity. Using CEST-NMR, we reveal that alpha-synuclein interacts with isolated synaptic vesicles with two regions, the N terminus, already known from studies on SUVs, and additionally via its C terminus, which is regulated by the binding of calcium. PMID: 29459792
    2. alphasynuclein induces apoptosis of astrocytes by causing dysfunction of the endoplasmic reticulumGolgi compartment. PMID: 29749529
    3. induces the clustering of synaptic vesicles by double-anchor mechanism PMID: 27640673
    4. The results suggest that Zn caused Ubiquitin proteasome system impairment, resulting in alpha-synuclein aggregation subsequently leading to dopaminergic neurodegeneration, and that Zn-induced Parkinsonism exhibited positive L-Dopa response similar to sporadic PD. PMID: 29198021
    5. FKBP12 contributes to alpha-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome. PMID: 29229832
    6. Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans PMID: 27708338
    7. E46K alpha-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation. PMID: 28900007
    8. These findings provide evidence for a novel mechanism underlying the protective effects of PINK1 against alpha-syn-induced neurodegeneration and highlight a novel therapeutic target for Parkinson's disease treatment. PMID: 28933786
    9. Using single-molecule microscopy and photo-bleaching approaches, the authors most frequently found 70 alpha-synuclein-green fluorescent fusion proteins per vesicle. Although this number is high enough to modulate physical membrane properties, it is also strikingly similar to the number of synaptobrevins, a putative interaction partner of alpha-synuclein, per vesicle. PMID: 27477055
    10. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases alpha-synuclein aggregation. PMID: 28193887
    11. we documented that ceftriaxone interacts with alpha-synuclein inhibiting its pathological aggregation and that a cyclical treatment with this molecule in a patient with adult-onset Alexander's disease halted, and partly reversed, the progression of neurodegeneration, suggests the possibility of a chaperone-like effect of ceftriaxone on protein involved in specific neurodegenerative diseases. PMID: 27133445
    12. The findings of this study confirm that alpha-synuclein interacts with membranes to affect Ca(2+) signalling in a structure-specific manner and the oligomeric beta-sheet-rich alpha-synuclein species ultimately leads to Ca(2+) dysregulation and Ca(2+)-dependent cell death. PMID: 26989132
    13. alpha-synuclein plays a crucial role in motor and sensory function regulation, in which, the underlying mechanism may be linked to the regulation of apoptosis associated with apoptotic gene (Bax, Bcl2) and neurotrophic factors expression (NGF, BDNF and NT3). PMID: 26822976
    14. the unaltered SNCA levels observed following ZSCAN21 down-regulation in the rat brain, possibly due to compensatory mechanisms, imply that ZSCAN21 is not a master regulator of SNCA in vivo. PMID: 26907683
    15. that loss of glucocerebrosidase function may contribute to SNCA accumulation through inhibition of autophagy via PPP2A inactivation PMID: 26378614
    16. We conclude that alphaSyn overexpression impairs neurite outgrowth and augments axonal degeneration, whereas axonal vesicle transport and autophagy are severely altered. PMID: 26158517
    17. The destabilization of physiological tetramers by PD-causing missense mutations and the neurotoxicity and inclusions induced by markedly decreasing tetramers suggest that decreased alpha-helical tetramers and increased unfolded monomers initiate pathogenesis. PMID: 26076669
    18. Results show that hydrostatic pressure is associated with a transition from monomeric to higher order alpha-synuclein aggregates and that increased pressure reduces the level of PLCbeta1 and the amount of alpha-synuclein/PLCbeta1 complexes. PMID: 26434717
    19. The data suggest that a-syn is involved in the regulation of synaptic plasticity in the ENS during early postnatal life and adult age. PMID: 25896939
    20. Mitochondrial impairment disturbs the autophagic flux and leads to the accumulation of exogenously applied alpha-synuclein PMID: 26212128
    21. the major toxic role of SNCA is related to its extracellular species and further supports a protective role of intracellular SNCA aggregation PMID: 25484190
    22. comparison between two types of alpha-synuclein showed that A53T mutated alpha-synuclein was more effective to establish a Parkinson disease (PD) model, and the model based A53T mutated alpha-synuclein was a suitable model for early-onset PD PMID: 26192120
    23. LRRK2 inhibition alleviates alpha-synuclein gene-induced neurodegeneration in the rat Parkinson's disease model. PMID: 26078453
    24. Cx3cl1 overexpression suppresses alpha-synuclein-mediated neurodegeneration. PMID: 25195598
    25. alpha-synuclein knockdown is neuroprotective in the rotenone model of PD and indicates that endogenous alpha-synuclein contributes to the specific vulnerability of dopaminergic neurons to systemic mitochondrial inhibition PMID: 26075822
    26. shed light on the potential roles of mutant alpha-synuclein in the pathogenesis of Parkinson's disease PMID: 24833599
    27. suggest that the N terminus of alpha-Syn is essential for the regulation of mitochondrial membrane permeability PMID: 25446002
    28. In the neuronal plasma membrane, alpha-synuclein caused synaptotoxic failure associated with a decrease in membrane proteins. PMID: 25669123
    29. a tight link between the intracellular level of alpha-synuclein and maturation capacity of primary oligodendrocyte progenitor cells PMID: 25019582
    30. These results suggest alpha-synuclein as a pathological link between chronic effects of traumatic brain injury and Parkinson's disease. PMID: 25251017
    31. It impairs maturation of oligodendrocyte progenitors thereby contributing to multiple system atrophy. PMID: 24698767
    32. CHIP can mediate the degradation of alpha synuclein aggregates in vivo PMID: 24664141
    33. extracellular ASN is involved in GSK-3beta-dependent Tau hyperphosphorylation, which leads to microtubule destabilization PMID: 24722055
    34. Results indicate the critical involvement of PAR2-NF-kappaB signaling in the upregulation of alpha-synuclein and motor dysfunction in the rodent model of Parkinsons disease. PMID: 24747612
    35. S-Nitrosylating protein disulphide isomerase plays a significant role in neurological disorders related to alpha-syn aggregation. PMID: 25090657
    36. LRRK2 expression in the wild-type rat midbrain remained undetected under nonpathological conditions, LRRK2 became highly expressed in iNOS-positive myeloid cells in the substantia nigra in response to alpha-synuclein overexpression or LPS exposures PMID: 24927544
    37. onjisaponin B was able to induce autophagy and accelerate both the removal of mutant huntingtin and A53T alpha-synuclein, which are highly associated with Huntington disease and Parkinson disease, respectively PMID: 24248062
    38. Changes in alpha-synuclein expression with age, including a baseline of accumulating synucleinopathies in the healthy aging submucosal plexus PMID: 23809578
    39. Our data show that changes in the S129 residue of alpha-synuclein influence the rate of pathology and neurodegeneration PMID: 23567651
    40. Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro. PMID: 23954626
    41. Inhibition of Nrf2/HO-1 leads to more alpha-syn aggregation and greater toxicity induced by iron, creating a vicious cycle of iron accumulation, alpha-syn aggregation and HO-1 disruption in PD. PMID: 23454680
    42. VDAC1 has a role in alpha-synuclein-induced dopaminergic neuron toxicity in rats PMID: 23291291
    43. Results suggest that macrophages play an active phagocytotic role in removing alpha-SYNC aggregates that accumulate with age in the neural circuitry of the gut. PMID: 23441091
    44. Accumulation of aggregated alpha-synuclein is triggered in substantia nigra in response to environmental toxins later in life. PMID: 23567316
    45. Exophagy, with or without expression of TPPP, may be an important physiological mechanism for unconventional secretion of alpha-synuclein from dopaminergic neurons. PMID: 23629650
    46. TFEB is a key player in the induction of alpha-synuclein-induced toxicity and Parkinson disease pathogenesis PMID: 23610405
    47. Our study is the first to evidence that enteric neurons are capable of secreting alpha-synuclein, thereby providing new insights into the role of the enteric nervous system in the pathophysiology of Parkinson disease. PMID: 23278133
    48. This study demonistrated that Deletion in exon 5 of the SNCA gene and exposure to rotenone leads to oligomerization of alpha-synuclein and toxicity to PC12 cells. PMID: 23128054
    49. Large alpha-Syn oligomers preferentially bind to the N-terminal domain of a vesicular SNARE protein, synaptobrevin-2, which blocks SNARE-mediated lipid mixing by preventing SNARE complex formation. PMID: 23431141
    50. Primary oligodendrocytes from rat brain and oligodendroglial cell lines take-up neuronal-secreted or exogenously added synuclein alpha from their conditioning medium. PMID: 23077527

    顯示更多

    收起更多

  • 亞細胞定位:
    Cytoplasm. Membrane. Nucleus. Cell junction, synapse. Secreted.
  • 蛋白家族:
    Synuclein family
  • 組織特異性:
    Found only in brain (hippocampus, brainstem and cortex). Specifically expressed in neuronal cell bodies and synapses.
  • 數據庫鏈接:

    KEGG: rno:29219

    UniGene: Rn.1827



主站蜘蛛池模板: 亚洲午夜精品一区二区| 免费观看全黄做爰大片国产| 苍井空张开腿实干12次| 久久九九久精品国产| 久久精品人人槡人妻人人玩av| 亚洲另类色区欧美日韩图片| 成人性生交大片免费看中文 | 欧美真人性野外做爰| 亚洲熟妇无码av不卡在线观看 | 亚洲国产精品久久人人爱| 久久无码中文字幕无码| 欧美另类 自拍 亚洲 图区| 亚洲人妻av伦理| 亚洲情xo亚洲色xo无码| 国产超碰人人做人人爽av| 国产乱人伦偷精精品视频| 天躁夜夜躁狼狠躁| 久久人妻无码中文字幕第一 | 潮喷大喷水系列无码| 欧美肉大捧一进一出免费视频| 亚洲欧洲成人av每日更新| 国产午夜成人无码免费| 久久午夜福利电影| 亚洲色婷婷久久精品av蜜桃 | 亚洲va久久久噜噜噜久久天堂 | 亚洲狠狠色丁香婷婷综合| 又粗又黄又爽视频免费看| 亚洲综合图色40p| 国产高清亚洲精品视bt天堂频| 成年女人午夜性视频| 激情影院内射美女| 日韩一区二区三区精品| 曰本一道本久久88不卡| 婷婷伊人五月尤物| 国产97在线 | 亚洲| 国产无套护士在线观看| 亚洲欧美日韩另类精品一区| 日产精品一区二区| 国产成人亚洲综合网色欲网| 日韩亚洲国产高清免费视频| 亚洲中文字幕无码中文字在线 |